Fig. S1 from The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors

Authors :: Zhe-Sheng Chen
Li-Wu Fu
Suresh V. Ambudkar
Dong-Hua Yang
Suneet Shukla
Li-Hua Huang
Bhargav A. Patel
Long-Hui Qiu
Rishil J. Kathawala
Yun-Kai Zhang
Yi-Jun Wang
Atish Patel
Hui Zhang
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Cytotoxicity assays of ibrutinib alone in the drug-resistant and parental cells.

Tools